PATENTS USE OF CYSTEINE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT INTENDED TO TREAT PATHOLOGIES WHICH RESULT FROM THE FORMATION OF THE HETEROTRIMERIC G PROTEIN

摘要

THE INVENTION RELATES TO THE USE OF CYSTEINE DERIVATIVES FOR PREPARING A MEDICAMENT INTENDED TO TREAT DISEASES WHICH RESULT FROM THE FORMATION OF THE HETEROTRIMERIC G PROTEIN. THESE DISEASES INCLUDE IN PARTICULAR DISEASES LINKED TO THE FOLLOWING BIOLOGICAL FUNCTIONS OR DISORDERS: SMELL, TASTE, PERCEPTION OF THE LIGHT, NEUROTRANSMISSION, NEURODEGENERATION, ENDOCRINE AND EXOCRINE GLAND FUNCTIONS, AUTOCRINE AND PARACRINE REGULATION, ARTERIAL TENSION, EMBRYOGENESIS, BENIGN CELL PROLIFERATION, ONCOGENESIS, VIRAL INFECTION, IMMUNOLOGICAL FUNCTIONS, DIABETES, OBESITY, AND BENIGN AND MALIGN PROLIFERATIVE DISEASES. SAID CYSTEINE DERIVATIVES INCLUDE IN PARTICULAR: -BIS-1,L'-[7-(2-AMINO-1-OXO-3-THIOPROPYL)-8-(CYCLOHEXYLMETHYL)-2-(2-METHOXYPHENYL)-5,6,7,8- TETRAHYDROIMIDAZO[1.2A]PYRAZINE DISULPHIDE (I), AND -BIS-1,1'-7-(2-AMINO-1-OXO-3-THIOPROPYL-(2-(1-NAPHTYL)-8-(2-METHYLPROPYL)-5,6,7,8-TETRAHYDROIMIDAZO[1.2A]PYRAZIN-7-YL) DISULPHIDE (II).